Argomenti e Notizie
sull'Osteoporosi
con raccolte
bibliografiche su
PubMed Logo
a cura del
Dott. C.Tarozzi
Bologna
Anno 19°
Num. 121
Recens. 2310
Aderiamo allo standard HONcode per l'affidabilità dell'informazione medica questo sito aderisce fin dal 2004 allo standard HONcode per l'affidabilità dell'informazione medica. Verifica qui.
Rassegna - Alimenti e Calcio - Questionari - T-Score - Valore di un Test - Calcolatori - Contatti - Digitalia - Radioactivity
Ricerca nell'archivio di questo sito...
 ?  
Nuova bibliografia selezionata fino al mese di marzo 2014 (recensioni 31) Ordina per Autore - Titolo - Rivista
Ward RJ, Weissman BN, Kransdorf MJ, Adler R, Appel M, Bancroft LW, Bernard SA, Bruno MA, Fries IB, Morrison WB, Mosher TJ, Roberts CC, Scharf SC, Tuite MJ, Zoga AC.
ACR Appropriateness Criteria Acute Hip Pain-Suspected Fracture.
J Am Coll Radiol. 2014 Feb;11(2):114-20.

Villiers J, Clark DW, Jeswani T, Webster S, Hepburn AL.
An atraumatic femoral fracture in a patient with rheumatoid arthritis and osteoporosis treated with denosumab.
Case Rep Rheumatol. 2013;

Alibasic E, Ramic E, Batic Mujanovic O, Avdibasic E, Husic D, Alic A.
Assessment of osteoporosis in family medicine obtained by ultrasound densitometry.
Acta Inform Med. 2013 Dec;21(4):274-6.

Leslie WD, Langsetmo L, Zhou W, Goltzman D, Kovacs CS, Prior J, Josse R, Olszynski WP, Davison KS, Anastassiades T, Towheed T, Hanley DA, Kaiser SM, Lentle B, Kreiger N; CaMos Research Group.
Choice of Lumbar Spine Bone Density Reference Database for Fracture Prediction in Men and Women: A Population-Based Analysis.
J Clin Densitom. 2014 Mar 7.

Bala Y, Zebaze R, Ghasem-Zadeh A, Atkinson EJ, Iuliano S, Peterson JM, Amin S, Bjørnerem A, Melton LJ 3rd, Johansson H, Kanis JA, Khosla S, Seeman E.
Cortical Porosity Identifies Women with Osteopenia at Increased Risk for Forearm Fractures.
J Bone Miner Res. 2014 Jan 14.

Simonelli C, Leib E, Mossman N, Winzenrieth R, Hans D, McClung M.
Creation of an Age-Adjusted, Dual-Energy X-ray Absorptiometry-Derived Trabecular Bone Score Curve for the Lumbar Spine in Non-Hispanic US White Women.
J Clin Densitom. 2014 Feb 25.

Adhikaree J, Newby Y, Sundar S.
Denosumab should be the treatment of choice for bisphosphonate refractory hypercalcaemia of malignancy.
BMJ Case Rep. 2014 Jan 30

Ristow O, Gerngroβ C, Schwaiger M, Hohlweg-Majert B, Kehl V, Jansen H, Hahnefeld L, Koerdt S, Otto S, Pautke C.
Effect of antiresorptive drugs on bony turnover in the jaw: denosumab compared with bisphosphonates.
Br J Oral Maxillofac Surg. 2014 Feb 26.

Cosmi F, Mazzoleni G.
Evaluation of the structural quality of bone in a case of progressive osteoporosis complicating a Complex Regional Pain Syndrome (CRPS) of the upper limb.
J Mech Behav Biomed Mater. 2014 Jan;29:517-28.

Baccaro LF, Machado Vde S, Costa-Paiva L, Sousa MH, Osis MJ, Pinto-Neto AM.
Factors associated with fragility fractures in women over 50 years of age: a population-based household survey.
Rev Bras Ginecol Obstet. 2013 Nov;35(11):497-502.

Ergen FB, Gulal G, Yildiz AE, Celik A, Karakaya J, Aydingoz U.
Fat Fraction Estimation of the Vertebrae in Females Using the T2*-IDEAL Technique in Detection of Reduced Bone Mineralization Level: Comparison With Bone Mineral Densitometry.
J Comput Assist Tomogr. 2013 Dec 27.

Bouvard B, Soulié P, Hoppé E, Georgin-Mege M, Royer M, Mesgouez-Nebout N, Lassalle C, Cellier P, Jadaud E, Abadie-Lacourtoisie S, Tuchais C, Vinchon-Petit S, Audran M, Chappard D, Legrand E.
Fracture incidence after 3 years of aromatase inhibitor therapy.
Ann Oncol. 2014 Mar 7.

Sims NA, Ng KW.
Implications of osteoblast-osteoclast interactions in the management of osteoporosis by antiresorptive agents denosumab and odanacatib.
Curr Osteoporos Rep. 2014 Mar;12(1):98-106.

Planas Morin J, Celma Domenech A, Placer Santos J, Trilla Herrera E, Salvador Lacambra C, Lorente Garcia D, Regis L, Carles Galceran J, Morote Robles
J. Bone mass behavior after 1 year of different treatment strategies in prostate cancer patients subjected to androgen deprivation therapy.
Rheumatol Int. 2014 Mar 11.

Khan MI, Syed GM, Khan AI, Sirwal IA, Anwar SK, Al-Oufi AR, Balbaid KA.
Mean bone mineral density and frequency of occurrence of osteopenia and osteoporosis in patients on hemodialysis: a single-center study.
Saudi J Kidney Dis Transpl. 2014 Jan;25(1):38-43.

Fusco V, Bedogni A, Campisi G.
Osteonecrosis of the jaw (ONJ) in renal cell cancer patients after treatment including zoledronic acid or denosumab.
Support Care Cancer. 2014 Feb 26.

Crandall CJ, Larson J, Gourlay ML, Donaldson MG, Lacroix A, Cauley JA, Wactawski-Wende J, Gass ML, Robbins JA, Watts NB, Ensrud KE.
Osteoporosis Screening in Postmenopausal Women 50-64 Years-Old: Comparison of U.S. Preventive Services Task Force Strategy and Two Traditional Strategies in the Women's Health Initiative.
J Bone Miner Res. 2014 Jan 16.

Lee JH, Lee YH, Moon SH, Lee YS;
Prevalence of Osteoporotic Vertebral Compression Fractures in Korean Post Menopausal Women Study Group. Influence of insurance benefit criteria on the administration rate of osteoporosis drugs in postmenopausal females.
Clin Orthop Surg. 2014 Mar;6(1):56-61

Gómez-de-Tejada Romero MJ, Navarro Rodríguez MD, Saavedra Santana P, Quesada Gómez JM, Jódar Gimeno E, Sosa Henríquez M.
Prevalence of osteoporosis, vertebral fractures and hypovitaminosis D in postmenopausal women living in a rural environment.
Maturitas. 2014 Mar;77(3):282-6.

Schousboe JT, Rosen HR, Vokes TJ, Cauley JA, Cummings SR, Nevitt M, Black DM, Orwoll ES, Kado DM, Ensrud KE;
Study of Osteoporotic Fractures Research Group. Prediction Models of Prevalent Radiographic Vertebral Fractures Among Older Women.
J Clin Densitom. 2014 Feb 25.

Mattei TA, Ramos E, Rehman AA, Shaw A, Patel SR, Mendel E.
Sustained Long-term Complete Regression of a Giant Cell Tumor of the Spine after Treatment with Denosumab.
Spine J. 2014 Feb 14.

Burch J, Rice S, Yang H, Neilson A, Stirk L, Francis R, Holloway P, Selby P, Craig D.
Systematic review of the use of bone turnover markers for monitoring the response to osteoporosis treatment: the secondary prevention of fractures, and primary prevention of fractures in high-risk groups.
Health Technol Assess. 2014 Feb;18(11)

Hangartner TN, Warner S, Braillon P, Jankowski L, Shepherd J.
The Official Positions of the International Society for Clinical Densitometry: acquisition of dual-energy X-ray absorptiometry body composition and considerations regarding analysis and repeatability of measures.
J Clin Densitom. 2013 Oct-Dec;16(4):520-36.

Sohn W, Simiens MA, Jaeger K, Hutton S, Jang G.
The Pharmacokinetics and Pharmacodynamics of Denosumab in Patients with Advanced Solid Tumours and Bone Metastases: A Systematic Review.
Br J Clin Pharmacol. 2014 Feb 18.

Lechner B, Deangelis C, Jamal N, Emmenegger U, Pulenzas N, Giotis A, Sheehan P, Tsao M, Bedard G, Chow E.
The effects of denosumab on calcium profiles in advanced cancer patients with bone metastases.
Support Care Cancer. 2014 Feb 11.

Capozzi A, Lello S, Pontecorvi A.
The inhibition of RANK-ligand in the management of postmenopausal osteoporosis and related fractures: the role of denosumab.
Gynecol Endocrinol. 2014 Mar 5.

Leder BZ, Tsai JN, Uihlein AV, Burnett-Bowie SA, Zhu Y, Foley K, Lee H, Neer RM.
Two Years of Denosumab and Teriparatide Administration in Postmenopausal Women with Osteoporosis (The DATA Extension Study): a Randomized Controlled Trial.
J Clin Endocrinol Metab. 2014 Feb 11

Mosali P, Bernard L, Wajed J, Mohamed Z, Ewang M, Moore A, Fogelman I, Hampson G.
Vitamin D Status and Parathyroid Hormone Concentrations Influence the Skeletal Response to Zoledronate and Denosumab.
Calcif Tissue Int. 2014 Feb 8.

Nagykálnai T, Landherr L.
[Management of bone metastases].
Orv Hetil. 2014 Feb 1;155(6):217-25

Yoneda T.
[New Diagnostic Criteria and Guidelines on Osteoporosis. Bisphosphonate-related osteonecrosis of the jaw-after a decade has passed].
Clin Calcium. 2014;24(3):407-15.

Uebelhart B, Rizzoli R.
[Osteoporosis].
Rev Med Suisse. 2014 Jan 15;10(412-413):101-7.

(Vers. 2.1)  Modificato il 16-3-2014
http://www.tarozzi.net   
questo sito aderisce ai principi HONCODE    disclaimer